홈 › 무증상 다발성 골수종 › 뉴욕
뉴욕의 무증상 다발성 골수종 임상 시험
무증상 다발성 골수종 관련 연구 8개가 뉴욕 내 여러 지역에서 참여자를 모집하고 있습니다.
뉴욕의 도시
공식 연구 텍스트(영어)
Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma
- Roswell Park Cancer Institute, Buffalo
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 11. 9. 업데이트됨 · NCT05312255A Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM)
- Memorial Sloan Kettering Cancer Center, New York
- Columbia University Medical Center, New York
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT07393282Screening for AL Amyloidosis in Smoldering Multiple Myeloma
- Columbia University Irving Medical Center, New York
- Memorial Sloan Kettering Cancer Center, New York
피험자 모집 중관찰 연구
40세 이상 · 모든 성별 · 2026. 10. 26. 업데이트됨 · NCT06365060A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- 외 1개
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 10. 5. 업데이트됨 · NCT06055894Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
- Hematology Oncology Associates of CNY at Camillus, Camillus
- Hematology Oncology Associates of Central New York-East Syracuse, East Syracuse
- Mount Sinai Chelsea, New York
- 외 2개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 8. 19. 업데이트됨 · NCT03937635A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma
- NYU Langone Health Perlmutter Cancer Center, New York
- Stony Brook University Hospital, Stony Brook
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 7. 8. 업데이트됨 · NCT06140524A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)
- Memorial Sloan Kettering Suffolk- Commack (All Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- 외 1개
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 4. 16. 업데이트됨 · NCT05640843Selinexor for the Treatment of Intermediate and High-Risk Smoldering Multiple Myeloma
- University of Rochester, Rochester
피험자 모집 중2상
18세 이상 · 모든 성별 · 2025. 2. 10. 업데이트됨 · NCT05597345ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.